DOTA(0)-Tyr(3)-Thr(8)- 111In-octreotate
can be used in peptide receptor-mediated radionuclide therapy
Also Known As:
111In-octreotate, DOTA(0)-Tyr(3)-Thr(8)-; 111In-0-DOTA-3-Tyr-8-Thr-octreotide; 111In-DOTATATE; 111In-octreotate, DOTA(0)-tyrosyl(3)-threonyl(8)-
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Atcher, Robert W:
1 article
(12/2016)
|
2. | Breeman, Wouter A:
1 article
(12/2016)
|
3. | Chan, Ho Sze:
1 article
(12/2016)
|
4. | Daniels, Tamara:
1 article
(12/2016)
|
5. | Konijnenberg, Mark W:
1 article
(12/2016)
|
6. | Makvandi, Mehran:
1 article
(12/2016)
|
7. | Norenberg, Jeffrey P:
1 article
(12/2016)
|
8. | Nysus, Monique:
1 article
(12/2016)
|
9. | de Blois, Erik:
1 article
(12/2016)
|
10. | de Jong, Marion:
1 article
(12/2016)
|
Related Diseases
Related Drugs and Biologics